180 related articles for article (PubMed ID: 24173369)
1. Combination of quercetin and hyperoside has anticancer effects on renal cancer cells through inhibition of oncogenic microRNA-27a.
Li W; Liu M; Xu YF; Feng Y; Che JP; Wang GC; Zheng JH
Oncol Rep; 2014 Jan; 31(1):117-24. PubMed ID: 24173369
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol and quercetin in combination have anticancer activity in colon cancer cells and repress oncogenic microRNA-27a.
Del Follo-Martinez A; Banerjee N; Li X; Safe S; Mertens-Talcott S
Nutr Cancer; 2013; 65(3):494-504. PubMed ID: 23530649
[TBL] [Abstract][Full Text] [Related]
3. The drug resistance suppression induced by curcuminoids in colon cancer SW-480 cells is mediated by reactive oxygen species-induced disruption of the microRNA-27a-ZBTB10-Sp axis.
Noratto GD; Jutooru I; Safe S; Angel-Morales G; Mertens-Talcott SU
Mol Nutr Food Res; 2013 Sep; 57(9):1638-48. PubMed ID: 23471840
[TBL] [Abstract][Full Text] [Related]
4. The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells.
Mertens-Talcott SU; Chintharlapalli S; Li X; Safe S
Cancer Res; 2007 Nov; 67(22):11001-11. PubMed ID: 18006846
[TBL] [Abstract][Full Text] [Related]
5. Combination of quercetin and hyperoside inhibits prostate cancer cell growth and metastasis via regulation of microRNA‑21.
Yang FQ; Liu M; Li W; Che JP; Wang GC; Zheng JH
Mol Med Rep; 2015 Feb; 11(2):1085-92. PubMed ID: 25354548
[TBL] [Abstract][Full Text] [Related]
6. GT-094, a NO-NSAID, inhibits colon cancer cell growth by activation of a reactive oxygen species-microRNA-27a: ZBTB10-specificity protein pathway.
Pathi SS; Jutooru I; Chadalapaka G; Sreevalsan S; Anand S; Thatcher GR; Safe S
Mol Cancer Res; 2011 Feb; 9(2):195-202. PubMed ID: 21156786
[TBL] [Abstract][Full Text] [Related]
7. Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs.
Gandhy SU; Kim K; Larsen L; Rosengren RJ; Safe S
BMC Cancer; 2012 Nov; 12():564. PubMed ID: 23194063
[TBL] [Abstract][Full Text] [Related]
8. Betulinic acid decreases ER-negative breast cancer cell growth in vitro and in vivo: role of Sp transcription factors and microRNA-27a:ZBTB10.
Mertens-Talcott SU; Noratto GD; Li X; Angel-Morales G; Bertoldi MC; Safe S
Mol Carcinog; 2013 Aug; 52(8):591-602. PubMed ID: 22407812
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of action of phenethylisothiocyanate and other reactive oxygen species-inducing anticancer agents.
Jutooru I; Guthrie AS; Chadalapaka G; Pathi S; Kim K; Burghardt R; Jin UH; Safe S
Mol Cell Biol; 2014 Jul; 34(13):2382-95. PubMed ID: 24732804
[TBL] [Abstract][Full Text] [Related]
10. Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors.
Chintharlapalli S; Papineni S; Lei P; Pathi S; Safe S
BMC Cancer; 2011 Aug; 11():371. PubMed ID: 21864401
[TBL] [Abstract][Full Text] [Related]
11. Sulindac sulfide inhibits colon cancer cell growth and downregulates specificity protein transcription factors.
Li X; Pathi SS; Safe S
BMC Cancer; 2015 Dec; 15():974. PubMed ID: 26673922
[TBL] [Abstract][Full Text] [Related]
12. Methyl 2-cyano-3,12-dioxooleana-1,9-dien-28-oate decreases specificity protein transcription factors and inhibits pancreatic tumor growth: role of microRNA-27a.
Jutooru I; Chadalapaka G; Abdelrahim M; Basha MR; Samudio I; Konopleva M; Andreeff M; Safe S
Mol Pharmacol; 2010 Aug; 78(2):226-36. PubMed ID: 20488920
[TBL] [Abstract][Full Text] [Related]
13. Combination of tolfenamic acid and curcumin induces colon cancer cell growth inhibition through modulating specific transcription factors and reactive oxygen species.
Sankpal UT; Nagaraju GP; Gottipolu SR; Hurtado M; Jordan CG; Simecka JW; Shoji M; El-Rayes B; Basha R
Oncotarget; 2016 Jan; 7(3):3186-200. PubMed ID: 26672603
[TBL] [Abstract][Full Text] [Related]
14. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
Shan BE; Wang MX; Li RQ
Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-27a Indirectly Regulates Estrogen Receptor {alpha} Expression and Hormone Responsiveness in MCF-7 Breast Cancer Cells.
Li X; Mertens-Talcott SU; Zhang S; Kim K; Ball J; Safe S
Endocrinology; 2010 Jun; 151(6):2462-73. PubMed ID: 20382698
[TBL] [Abstract][Full Text] [Related]
16. Piperlongumine Induces Reactive Oxygen Species (ROS)-Dependent Downregulation of Specificity Protein Transcription Factors.
Karki K; Hedrick E; Kasiappan R; Jin UH; Safe S
Cancer Prev Res (Phila); 2017 Aug; 10(8):467-477. PubMed ID: 28673967
[TBL] [Abstract][Full Text] [Related]
17. The cannabinoid WIN 55,212-2 decreases specificity protein transcription factors and the oncogenic cap protein eIF4E in colon cancer cells.
Sreevalsan S; Safe S
Mol Cancer Ther; 2013 Nov; 12(11):2483-93. PubMed ID: 24030632
[TBL] [Abstract][Full Text] [Related]
18. Betulinic acid targets YY1 and ErbB2 through cannabinoid receptor-dependent disruption of microRNA-27a:ZBTB10 in breast cancer.
Liu X; Jutooru I; Lei P; Kim K; Lee SO; Brents LK; Prather PL; Safe S
Mol Cancer Ther; 2012 Jul; 11(7):1421-31. PubMed ID: 22553354
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity of pomegranate polyphenolics in breast cancer cells in vitro and vivo: potential role of miRNA-27a and miRNA-155 in cell survival and inflammation.
Banerjee N; Talcott S; Safe S; Mertens-Talcott SU
Breast Cancer Res Treat; 2012 Nov; 136(1):21-34. PubMed ID: 22941571
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate in colon cancer cells.
Chintharlapalli S; Papineni S; Abdelrahim M; Abudayyeh A; Jutooru I; Chadalapaka G; Wu F; Mertens-Talcott S; Vanderlaag K; Cho SD; Smith R; Safe S
Int J Cancer; 2009 Oct; 125(8):1965-74. PubMed ID: 19582879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
